Transcription termination factor Pcf11 limits the processivity of Pol II on an HIV provirus to repress gene expression

Genes and Development

Volumn 21, Issue 13, 2007, Pages 1609-1614

  Zhang, Zhiqiang ^a   Klatt, Alicia ^a   Henderson, Andrew J ^a,b   Gilmour, David S ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Gene expression; HIV; RNA polymerase II; Transcription termination

Indexed keywords

6 DICHLORO 1 BETA DEXTRO RIBOFURANOSYLBENZIMIDAZOLE; BENZIMIDAZOLE DERIVATIVE; RNA POLYMERASE II; TRANSCRIPTION FACTOR; TRANSCRIPTION TERMINATION FACTOR PCF11; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; EUKARYOTIC CELL; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; VIRUS TRANSCRIPTION;

ANIMALS; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; DICHLORORIBOFURANOSYLBENZIMIDAZOLE; DOWN-REGULATION; GENE EXPRESSION REGULATION, VIRAL; HELA CELLS; HIV; HUMANS; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; PROMOTER REGIONS (GENETICS); PROVIRUSES; RNA POLYMERASE II; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC;

EUKARYOTA;

EID: 34347401642     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1542707     Document Type: Article

References (37)

1. Aiyar, S.E., Sun, J.L., Blair, A.L., Moskaluk, C.A., Lu, Y.Z., Ye, Q.N., Yamaguchi, Y., Mukherjee, A., Ren, D.M., Handa, H., et al. 2004. Attenuation of estrogen receptor α-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor. Genes & Dev. 18: 2134-2146.
2. Buratowski, S. 2005. Connections between mRNA 3′ end processing and transcription termination. Curr. Opin. Cell Biol. 17: 257-261.
3. Cook, J.A., Albacker, L., August, A., and Henderson, A.J. 2003. CD28-dependent HIV-1 transcription is associated with Vav, Rac, and NF-κ B activation. J. Biol. Chem. 278: 35812-35818.
4. Cullen, B.R. 1990. The HIV-1 Tat protein: An RNA sequence-specific processivity factor. Cell 63: 655-657.
5. Cullen, B.R. 1991. Regulation of HIV-1 gene expression. FASEB J. 5: 2361-2368.
6. de Vries, H., Ruegsegger, U., Hubner, W., Friedlein, A., Langen, H., and Keller, W. 2000. Human pre-mRNA cleavage factor II(m) contains homologs of yeast proteins and bridges two other cleavage factors. EMBO J. 19: 5895-5904.
7. Feinberg, M.B., Baltimore, D., and Frankel, A.D. 1991. The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc. Natl. Acad. Sci. 88: 4045-4049.
8. Folks, T.M., Justement, J., Kinter, A., Dinarello, C.A., and Fauci, A.S. 1987. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 238: 800-802.
9. Folks, T.M., Justement, J., Kinter, A., Schnittman, S., Orenstein, J., Poli, G., and Fauci, A.S. 1988. Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. J. Immunol. 140: 1117-1122.
10. Fraser, N.W., Sehgal, P.B., and Darnell Jr., J.E. 1979. Multiple discrete sites for premature RNA chain termination late in adenovirus-2 infection: Enhancement by 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole. Proc. Natl. Acad. Sci. 76: 2571-2575.
11. Harlow, E. and Lane, D. 1999. Using antibodies: A laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
12. Izban, M.G. and Luse, D.S. 1991. Transcription on nucleosomal templates by RNA polymerase II in vitro: Inhibition of elongation with enhancement of sequence-specific pausing. Genes & Dev. 5: 683-696.
13. Jiang, Y., Liu, M., Spencer, C.A., and Price, D.H. 2004. Involvement of transcription termination factor 2 in mitotic repression of transcription elongation. Mol. Cell 14: 375-385.
14. Kao, S.Y., Calman, A.F., Luciw, P.A., and Peterlin, B.M. 1987. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature 330: 489-493.
15. Kessler, M. and Mathews, M.B. 1992. Premature termination and processing of human immunodeficiency virus type 1-promoted transcripts. J. Virol. 66: 4488-4496.
16. Kim, M., Ahn, S.H., Krogan, N.J., Greenblatt, J.F., and Buratowski, S. 2004. Transitions in RNA polymerase II elongation complexes at the 3′ ends of genes. EMBO J. 23: 354-364.
17. Lam, L.T., Pickeral, O.K., Peng, A.C., Rosenwald, A., Hurt, E.M., Giltnane, J.M., Averett, L.M., Zhao, H., Davis, R.E., Sathyamoorthy, M., et al. 2001. Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biol. doi: 10.1186/gb-2001-2-10-research0041.
18. Laspia, M.F., Rice, A.P., and Mathews, M.B. 1989. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell 59: 283-292.
19. Licatalosi, D.D., Geiger, G., Minet, M., Schroeder, S., Cilli, K., McNeil, J.B., and Bentley, D.L. 2002. Functional interaction of yeast premRNA 3′ end processing factors with RNA polymerase II. Mol. Cell 9: 1101-1111.
20. Mancebo, H.S., Lee, G., Flygare, J., Tomassini, J., Luu, P., Zhu, Y., Peng, J., Blau, C., Hazuda, D., Price, D., et al. 1997. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes & Dev. 11: 2633-2644.
21. Marciniak, R.A. and Sharp, P.A. 1991. HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO J. 10: 4189-4196.
22. Mason, P.B. and Struhl, K. 2005. Distinction and relationship between elongation rate and processivity of RNA polymerase II in vivo. Mol. Cell 17: 831-840.
23. Peterlin, B.M. and Price, D.H. 2006. Controlling the elongation phase of transcription with P-TEFb. Mol. Cell 23: 297-305.
24. Raha, T., Cheng, S.W., and Green, M.R. 2005. HIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs. PLoS Biol. doi: 10.1371/journal.pbio.0030044.
25. Renner, D.B., Yamaguchi, Y., Wada, T., Handa, H., and Price, D.H. 2001. A highly purified RNA polymerase II elongation control system. J. Biol. Chem. 276: 42601-42609.
26. Rosonina, E., Kaneko, S., and Manley, J.L. 2006. Terminating the transcript: Breaking up is hard to do. Genes & Dev. 20: 1050-1056.
27. Saunders, A., Core, L.J., and Lis, J.T. 2006. Breaking barriers to transcription elongation. Nat. Rev. 7: 557-567.
28. Sims III, R.J., Belotserkovskaya, R., and Reinberg, D. 2004. Elongation by RNA polymerase II: The short and long of it. Genes & Dev. 18: 2437-2468.
29. Tamm, I., Kikuchi, T., Darnell Jr., J.E., and Salditt-Georgieff, M. 1980. Short capped hnRNA precursor chains in HeLa cells: Continued synthesis in the presence of 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole. Biochemistry 19: 2743-2748.
30. Toohey, M.G. and Jones, K.A. 1989. In vitro formation of short RNA polymerase II transcripts that terminate within the HIV-1 and HIV-2 promoter-proximal downstream regions. Genes & Dev. 3: 265-282.
31. Verdin, E., Paras Jr., P., and Van Lint, C. 1993. Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J. 12: 3249-3259.
32. Wada, T., Takagi, T., Yamaguchi, Y., Ferdous, A., Imai, T., Hirose, S., Sugimoto, S., Yano, K., Hartzog, G.A., Winston, F., et al. 1998. DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes & Dev. 12: 343-356.
33. West, S., Gromak, N., and Proudfoot, N.J. 2004. Human 5′ → 3′ exonuclease Xrn2 promotes transcription termination at co-transcriptional cleavage sites. Nature 432: 522-525.
34. Yamaguchi, Y., Takagi, T., Wada, T., Yano, K., Furuya, A., Sugimoto, S., Hasegawa, J., and Handa, H. 1999. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 97: 41-51.
35. Zhang, Z. and Gilmour, D.S. 2006. Pcf11 is a termination factor in Drosophila that dismantles the elongation complex by bridging the CTD of RNA polymerase II to the nascent transcript. Mol. Cell 21: 65-74.
36. Zhang, Z., Fu, J., and Gilmour, D.S. 2005. CTD-dependent dismantling of the RNA polymerase II elongation complex by the pre-mRNA 3′-end processing factor, Pcf11. Genes & Dev. 19: 1572-1580.
37. Zhang, Z., Klatt, A., Gilmour, D.S., and Henderson, A.J. 2007. Negative elongation factor, NELF, represses human immunodeficiency virus transcription by pausing the RNA polymerase II complex. J. Biol. Chem. doi: 10.0074/jbc.M610688200.